caffeine has been researched along with Apoplexy in 24 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "PubMed, Web of Science, Scopus, Cochrane and Google Scholar were searched using terms related to coffee, caffeine and kidney stones to find eligible articles up to December 2021." | 9.22 | Caffeine intake and the risk of incident kidney stones: a systematic review and meta-analysis. ( Huang, Y; Yu, X; Zhao, J, 2022) |
| " Nineteen patients recovering from an acute ischaemic stroke in the middle cerebral artery territory and 10 controls attended two sessions, having abstained from caffeine for 48 hours previously." | 9.11 | Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke. ( Birch, A; Jenkinson, DF; Lunt, M; Ragab, S; Thomas, P, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 8.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 8.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "This study investigates the potential correlation between urinary caffeine levels and the occurrence of stroke, a serious cerebrovascular disease that can lead to disability or death." | 8.31 | Association between urinary caffeine and caffeine metabolites and stroke in American adults: a cross-sectional study from the NHANES, 2009-2014. ( Fan, J; Gu, J; Li, W; Ma, W; Wang, W; Yuan, Y; Zhang, X; Zhou, B, 2023) |
| "Research on the relationship between caffeine-containing medicines (CCMs) and the risk of hemorrhagic stroke (HS) is sparse." | 7.79 | Caffeine-containing medicines increase the risk of hemorrhagic stroke. ( Cho, KH; Choi, NK; Lee, BC; Lee, SM; Park, BJ; Yoon, BW, 2013) |
| "PubMed, Web of Science, Scopus, Cochrane and Google Scholar were searched using terms related to coffee, caffeine and kidney stones to find eligible articles up to December 2021." | 5.22 | Caffeine intake and the risk of incident kidney stones: a systematic review and meta-analysis. ( Huang, Y; Yu, X; Zhao, J, 2022) |
| " Nineteen patients recovering from an acute ischaemic stroke in the middle cerebral artery territory and 10 controls attended two sessions, having abstained from caffeine for 48 hours previously." | 5.11 | Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke. ( Birch, A; Jenkinson, DF; Lunt, M; Ragab, S; Thomas, P, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 4.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 4.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "This study investigates the potential correlation between urinary caffeine levels and the occurrence of stroke, a serious cerebrovascular disease that can lead to disability or death." | 4.31 | Association between urinary caffeine and caffeine metabolites and stroke in American adults: a cross-sectional study from the NHANES, 2009-2014. ( Fan, J; Gu, J; Li, W; Ma, W; Wang, W; Yuan, Y; Zhang, X; Zhou, B, 2023) |
| "Research on the relationship between caffeine-containing medicines (CCMs) and the risk of hemorrhagic stroke (HS) is sparse." | 3.79 | Caffeine-containing medicines increase the risk of hemorrhagic stroke. ( Cho, KH; Choi, NK; Lee, BC; Lee, SM; Park, BJ; Yoon, BW, 2013) |
| "Neurodegenerative disorders are some of the most feared illnesses in modern society, with no effective treatments to slow or halt this neurodegeneration." | 2.47 | Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies. ( Chen, JF; Chern, Y, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Redondo, M | 1 |
| Zarruk, JG | 1 |
| Ceballos, P | 1 |
| Pérez, DI | 1 |
| Pérez, C | 1 |
| Perez-Castillo, A | 1 |
| Moro, MA | 1 |
| Brea, J | 1 |
| Val, C | 1 |
| Cadavid, MI | 1 |
| Loza, MI | 1 |
| Campillo, NE | 1 |
| Martínez, A | 1 |
| Gil, C | 1 |
| Zhao, J | 1 |
| Huang, Y | 1 |
| Yu, X | 1 |
| Inoue-Choi, M | 1 |
| Ramirez, Y | 1 |
| Cornelis, MC | 1 |
| Berrington de González, A | 1 |
| Freedman, ND | 1 |
| Loftfield, E | 1 |
| Fan, J | 1 |
| Yuan, Y | 1 |
| Zhang, X | 1 |
| Li, W | 1 |
| Ma, W | 1 |
| Wang, W | 1 |
| Gu, J | 1 |
| Zhou, B | 1 |
| Lee, SM | 1 |
| Choi, NK | 1 |
| Lee, BC | 1 |
| Cho, KH | 1 |
| Yoon, BW | 1 |
| Park, BJ | 1 |
| Zhang, C | 1 |
| Qin, YY | 1 |
| Wei, X | 1 |
| Yu, FF | 1 |
| Zhou, YH | 1 |
| He, J | 1 |
| Venkatraman, A | 1 |
| Khawaja, A | 1 |
| Shapshak, AH | 1 |
| Hallevi, H | 1 |
| Aronowski, J | 2 |
| Mineharu, Y | 1 |
| Koizumi, A | 1 |
| Wada, Y | 1 |
| Iso, H | 1 |
| Watanabe, Y | 1 |
| Date, C | 1 |
| Yamamoto, A | 1 |
| Kikuchi, S | 1 |
| Inaba, Y | 1 |
| Toyoshima, H | 1 |
| Kondo, T | 1 |
| Tamakoshi, A | 1 |
| Chen, JF | 1 |
| Chern, Y | 1 |
| Larsson, SC | 1 |
| Virtamo, J | 1 |
| Wolk, A | 1 |
| Miller, M | 1 |
| Kumar, AB | 1 |
| Callison, CR | 1 |
| Floegel, A | 1 |
| Pischon, T | 1 |
| Bergmann, MM | 1 |
| Teucher, B | 1 |
| Kaaks, R | 1 |
| Boeing, H | 1 |
| Montagnana, M | 1 |
| Favaloro, EJ | 1 |
| Lippi, G | 1 |
| Sekiguchi, F | 1 |
| Kawata, K | 1 |
| Shimamura, K | 1 |
| Sunano, S | 1 |
| Piriyawat, P | 1 |
| Labiche, LA | 1 |
| Burgin, WS | 1 |
| Aronowski, JA | 1 |
| Grotta, JC | 2 |
| Ragab, S | 1 |
| Lunt, M | 1 |
| Birch, A | 1 |
| Thomas, P | 1 |
| Jenkinson, DF | 2 |
| Hoyte, L | 1 |
| Kaur, J | 1 |
| Buchan, AM | 1 |
| Bath, PM | 2 |
| Zhao, X | 1 |
| Liu, SJ | 1 |
| Zhang, J | 1 |
| Strong, R | 1 |
| Rempher, KJ | 1 |
| Mohiuddin, AA | 1 |
| Bath, FJ | 1 |
| Lunt, MJ | 1 |
| Hanrahan, A | 1 |
| Kerr, D | 1 |
7 reviews available for caffeine and Apoplexy
| Article | Year |
|---|---|
Caffeine intake and the risk of incident kidney stones: a systematic review and meta-analysis.
Topics: Caffeine; Cohort Studies; Humans; Incidence; Kidney Calculi; Risk Factors; Stroke | 2022 |
Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies.
Topics: Caffeine; Cardiovascular Diseases; Cerebral Hemorrhage; Coronary Disease; Female; Humans; Mortality; | 2015 |
Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Topics: Alzheimer Disease; Animals; Brain Injuries; Caffeine; Humans; Huntington Disease; Neurodegenerative | 2011 |
Lost in translation: taking neuroprotection from animal models to clinical trials.
Topics: Animals; Brain Ischemia; Caffeine; Cerebral Hemorrhage; Disease Models, Animal; Drug Therapy, Combin | 2004 |
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Randomized Controlled Trials as Topic; Stroke; Theo | 2004 |
Cardiovascular sequelae of tobacco smoking.
Topics: Aortic Aneurysm, Abdominal; Arrhythmias, Cardiac; Atherosclerosis; Caffeine; Cardiovascular Diseases | 2006 |
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Stroke; Theophylline; Vasodilator Agents | 2000 |
3 trials available for caffeine and Apoplexy
| Article | Year |
|---|---|
Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Caffeine; Cerebral Hemorrhage; Drug Therapy, Combina | 2003 |
Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Brain Ischemia; Caffeine; Central Nervous System Stimu | 2004 |
Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Blood Flow Velocity; Brain Ischemia; Caffeine; Central Nervo | 2002 |
14 other studies available for caffeine and Apoplexy
| Article | Year |
|---|---|
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
Topics: Animals; Blood-Brain Barrier; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease | 2012 |
Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
Topics: Biological Specimen Banks; Caffeine; Cardiovascular Diseases; Cause of Death; Coffee; Female; Follow | 2022 |
Association between urinary caffeine and caffeine metabolites and stroke in American adults: a cross-sectional study from the NHANES, 2009-2014.
Topics: Adult; Caffeine; Cross-Sectional Studies; Humans; Nutrition Surveys; Prospective Studies; Stroke; Un | 2023 |
Caffeine-containing medicines increase the risk of hemorrhagic stroke.
Topics: Adult; Aged; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Cerebral Hemorrhage; | 2013 |
Hemorrhagic stroke after consumption of an energy drink.
Topics: Caffeine; Central Nervous System Stimulants; Energy Drinks; Humans; Intracranial Hemorrhages; Stroke | 2017 |
Life after SAINT.
Topics: Albumins; Antioxidants; Benzenesulfonates; Caffeine; Cerebral Hemorrhage; Clinical Trials, Phase II | 2007 |
Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Beverages; Caffeine; Cardiovascular Diseases; Coffe | 2011 |
Coffee consumption and risk of stroke in women.
Topics: Adult; Aged; Aged, 80 and over; Caffeine; Cerebral Infarction; Coffee; Cohort Studies; Female; Human | 2011 |
Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
Topics: Adult; Caffeine; Cerebral Angiography; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; | 2012 |
Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diabetes Mellitus, Type 2; F | 2012 |
Coffee intake and cardiovascular disease: virtue does not take center stage.
Topics: Adult; Animals; Beverages; Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Cholesterol; Coffee; | 2012 |
Reduced effect of caffeine on twitch contraction of oesophageal striated muscle from stroke-prone spontaneously hypertensive rats.
Topics: Animals; Caffeine; Esophagus; In Vitro Techniques; Membrane Potentials; Muscle Contraction; Muscle R | 2003 |
Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
Topics: Animals; Behavior, Animal; Caffeine; Drug Combinations; Drug Therapy, Combination; Ethanol; Infarcti | 2005 |
Coffee and alcohol combination may protect stroke patients.
Topics: Animals; Brain Infarction; Caffeine; Drug Combinations; Ethanol; Humans; Rats; Stroke | 2003 |